Lille, France

Flavien Vincent

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Ctre Hospitalier Universitaire De Lille, Laboratoire Francais Du Fractionnement Et Des Biotechnologies, Université Lille 2 - Droit Et Santé. Active years: 2019.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Flavien Vincent: Innovator in Hematology

Introduction

Flavien Vincent is a notable inventor based in Lille, France. He has made significant contributions to the field of hematology, particularly in the prevention and treatment of hemorrhage in patients with mechanical circulatory support. His innovative work has the potential to improve patient outcomes in critical care settings.

Latest Patents

Flavien Vincent holds a patent for the use of von Willebrand factor. The present invention relates to a von Willebrand factor composition for the prevention and/or treatment of hemorrhage and/or bleeding in patients with mechanical circulatory support. This patent highlights his commitment to advancing medical science and improving patient care.

Career Highlights

Vincent has worked at prestigious institutions, including the Centre Hospitalier Universitaire de Lille and Université Lille 2 - Droit et Santé. His roles in these organizations have allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Throughout his career, Flavien Vincent has collaborated with notable colleagues such as Eric Van Belle and Antoine Rauch. These partnerships have fostered an environment of innovation and have led to significant advancements in their shared field of study.

Conclusion

Flavien Vincent's contributions to the field of hematology through his patent and collaborative efforts demonstrate his dedication to improving medical treatments. His work continues to inspire future innovations in patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…